» Articles » PMID: 29293097

Resolution of Organ Fibrosis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2018 Jan 3
PMID 29293097
Citations 147
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrosis is the excessive accumulation of extracellular matrix that often occurs as a wound healing response to repeated or chronic tissue injury, and may lead to the disruption of organ architecture and loss of function. Although fibrosis was previously thought to be irreversible, recent evidence indicates that certain circumstances permit the resolution of fibrosis when the underlying causes of injury are eradicated. The mechanism of fibrosis resolution encompasses degradation of the fibrotic extracellular matrix as well as elimination of fibrogenic myofibroblasts through their adaptation of various cell fates, including apoptosis, senescence, dedifferentiation, and reprogramming. In this Review, we discuss the present knowledge and gaps in our understanding of how matrix degradation is regulated and how myofibroblast cell fates can be manipulated, areas that may identify potential therapeutic approaches for fibrosis.

Citing Articles

Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy.

Sacchi M, Tomaselli D, Ruggeri M, Aiello F, Sabella P, Dore S Int J Mol Sci. 2025; 26(5).

PMID: 40076946 PMC: 11900438. DOI: 10.3390/ijms26052327.


Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis.

Lin H, Wang X, Chung M, Cai S, Pan Y J Transl Med. 2025; 23(1):240.

PMID: 40016790 PMC: 11869441. DOI: 10.1186/s12967-024-06060-3.


State of the ART: Drug Screening Reveals Artesunate as a Promising Anti-Fibrosis Therapy.

Qiao Y, Liang J, Jiang D J Respir Biol Transl Med. 2025; 2(1).

PMID: 39925974 PMC: 11800322. DOI: 10.70322/jrbtm.2024.10023.


The Novel Effect and Potential Mechanism of Lactoferrin on Organ Fibrosis Prevention.

Yu Y, Fang J, Li Y, Wang X, Zhang J, Wang J Nutrients. 2025; 17(1.

PMID: 39796631 PMC: 11723014. DOI: 10.3390/nu17010197.


Physical Exercise: A Promising Treatment Against Organ Fibrosis.

Ma X, Liu B, Jiang Z, Rao Z, Zheng L Int J Mol Sci. 2025; 26(1.

PMID: 39796197 PMC: 11720236. DOI: 10.3390/ijms26010343.


References
1.
Ikenaga N, Peng Z, Vaid K, Liu S, Yoshida S, Sverdlov D . Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. Gut. 2017; 66(9):1697-1708. PMC: 5561383. DOI: 10.1136/gutjnl-2016-312473. View

2.
Szardien S, Nef H, Voss S, Troidl C, Liebetrau C, Hoffmann J . Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1β synthesis. Eur Heart J. 2011; 33(5):595-605. DOI: 10.1093/eurheartj/ehr434. View

3.
Stramer B, Mori R, Martin P . The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol. 2007; 127(5):1009-17. DOI: 10.1038/sj.jid.5700811. View

4.
Karimi-Shah B, Chowdhury B . Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib. N Engl J Med. 2015; 372(13):1189-91. DOI: 10.1056/NEJMp1500526. View

5.
Flechsig P, Hartenstein B, Teurich S, Dadrich M, Hauser K, Abdollahi A . Loss of matrix metalloproteinase-13 attenuates murine radiation-induced pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 2010; 77(2):582-90. DOI: 10.1016/j.ijrobp.2009.12.043. View